Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2000
09/20/2000EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
09/20/2000EP1035863A1 An over-expressing homologous antigen vaccine and a method of making the same
09/20/2000EP1035862A2 Cyclosporin-containing microemulsion preconcentrate composition
09/20/2000EP1035845A1 Modulators of cysteine protease
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000EP1035780A1 Method for purifying heat shock peptides complexes
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000CN1267221A Method of enhancing bioavailability of fexofenadine and its derivs.
09/20/2000CN1266712A Oral liquid for preventing altitude disease and its preparing process
09/20/2000CN1266683A Medicinal composition containing dihydroartemisine for treating rosacea and photosensitive diseases
09/20/2000CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same
09/20/2000CN1056608C Pseudodipeptide product having imidazole group and applications
09/20/2000CN1056602C Esters and amides as PLAZ inhibitors
09/20/2000CN1056522C Health-care tonic liquor and its producing method
09/20/2000CN1056520C Anti-senility hypolpemic Chinese medicine liquor
09/20/2000CN1056511C Process for preparing composition for beauty or pharmaceutical, especially dermotoses and antiallergy by using cucurbin, and use
09/19/2000US6121479 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
09/19/2000US6121424 Immunogen association polypeptides with at least two preferences; for the delivery of cells, cytotoxins, or drugs to preferential positioning
09/19/2000US6121329 Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol
09/19/2000US6121325 Naphthyl compounds promote release of growth hormone
09/19/2000US6121313 Pharmaceutical composition in a form of self-emulsifying formulation for lipophilic compounds
09/19/2000US6121287 Quinoline derivatives
09/19/2000US6121280 Azabicyclic rotomase inhibitors
09/19/2000US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders
09/19/2000US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders
09/19/2000US6121257 Sulfamate containing macrocyclic immunomodulators
09/19/2000US6121243 Prophylaxis of skin against ageing, against inflammation and for protection from photoreaction and oxidative influences
09/19/2000US6121044 Potent antigen presenting cell composition
09/19/2000US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases
09/19/2000US6120807 Prolonged release of GM-CSF
09/19/2000US6120777 High fluorescence specific immune enhancing factor and methods of use for same
09/19/2000US6120769 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
09/19/2000US6120766 CDW52-specific antibody for treatment of multiple sclerosis
09/19/2000US6120763 Compositions and methods for enhanced tumor cell immunity in vivo
09/19/2000CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed
09/19/2000CA2184914C Isoxazoline compounds as 5-lipoxygenase inhibitors
09/19/2000CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them
09/14/2000WO2000053790A1 Target cell-specific, multivalent proteins (mvp)
09/14/2000WO2000053786A1 Stable recombinant influenza viruses free of helper viruses
09/14/2000WO2000053767A2 Nucleic acid respiratory syncytial virus vaccines
09/14/2000WO2000053748A2 Casb618 polynucleotides and polypeptides and their use
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
09/14/2000WO2000053631A1 Mammalian cytokines; related reagents and methods
09/14/2000WO2000053604A1 Carbamoyl tetrahydropyridine derivatives
09/14/2000WO2000053602A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053600A1 Novel piperidine derivatives
09/14/2000WO2000053596A2 Imidazole compounds as histamine h3 ligands
09/14/2000WO2000053572A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
09/14/2000WO2000053563A1 Novel ligands of nuclear receptors ppar's
09/14/2000WO2000053562A1 Retinoid antagonists and use thereof
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053222A1 Enhancing immune response in animals
09/14/2000WO2000053219A2 Compositions and methods for treating cancer and hyperproliferative disorders
09/14/2000WO2000053212A1 Pharmaceutical composition containing cyclosporin
09/14/2000WO2000053190A1 Novel immunosuppressants
09/14/2000WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053177A1 Liposome preparations
09/14/2000WO2000053171A1 Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv
09/14/2000WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation
09/14/2000WO2000053019A1 Dna vaccination for treatment of autoimmune disease
09/14/2000WO2000037504A3 Human monoclonal antibodies to ctla-4
09/14/2000WO2000037422A3 Ion channel modulating agents
09/14/2000WO2000037102A3 Improvement of tolerance to a xenograft
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000031132A8 Novel polypeptide
09/14/2000WO2000025812A3 Method for preparing solid phase conjugate vaccines
09/14/2000DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation
09/14/2000DE19910159A1 Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung Specific IgY-egg yolk, their production and their use
09/14/2000CA2367315A1 Apoptosis inducing molecule ii and methods of use
09/14/2000CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases
09/14/2000CA2366706A1 Mammalian cytokines; related reagents and methods
09/14/2000CA2366642A1 Carbamoyl tetrahydropyridine derivatives
09/14/2000CA2366615A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2366281A1 Novel ligands of nuclear receptors ppar's
09/14/2000CA2366147A1 Casb618 polynucleotides and polypeptides and their use
09/14/2000CA2365813A1 Stable recombinant influenza viruses free of helper viruses
09/14/2000CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000CA2364503A1 Compositions and methods for treating cancer and hyperproliferative disorders
09/14/2000CA2364257A1 Liposome preparations
09/14/2000CA2363593A1 Nucleic acid respiratory syncytial virus vaccines
09/14/2000CA2362422A1 Polynucleotides and proteins encoded thereby
09/14/2000CA2362319A1 Imidazole compounds as histamine h3 ligands
09/13/2000EP1035209A1 Stable recombinant influenza viruses free of helper viruses
09/13/2000EP1034795A2 Conjugates of lipids and biologically active compounds
09/13/2000EP1034789A1 Type-2 chemokine binding proteins and methods of use therefor
09/13/2000EP1034301A1 Inhibition of an fgf-binding protein using ribozymes
09/13/2000EP1034295A1 ribA
09/13/2000EP1034276A1 Novel era
09/13/2000EP1034272A1 A cDNA ENCODING C6 $g(b)-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
09/13/2000EP1034265A1 Human cdc10 homolog
09/13/2000EP1034171A1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl1]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
09/13/2000EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors
09/13/2000EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
09/13/2000EP1034001A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome
09/13/2000EP1034000A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
09/13/2000EP1033989A1 Method for reducing mast cell mediated allergic reactions
09/13/2000EP1033983A1 Cyclic amino acid derivatives as cell adhesion inhibitors
1 ... 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 ... 1172